Mesenchymal stem cells and extracellular vesicles for knee osteoarthritis: clinical application, mechanism exploration and prospect | Stem Cell Research & Therapy

  • Gelber AC. Knee osteoarthritis. Ann Intern Med. 2024;177(9):ITC129–129144.

    Google Scholar 

  • Yang G, Wang J, Liu Y, et al. Burden of knee osteoarthritis in 204 countries and Territories, 1990–2019: results from the global burden of disease study 2019. Arthritis Care Res (Hoboken). 2023;75(12):2489–500.

    Google Scholar 

  • Li E, Tan J, Xu K, Pan Y, Xu P. Global burden and socioeconomic impact of knee osteoarthritis: a comprehensive analysis. Front Med (Lausanne). 2024;11:1323091.

    Google Scholar 

  • Katz JN, Arant KR, Loeser RF. Diagnosis and treatment of hip and knee osteoarthritis: A review. JAMA. 2021;325(6):568–78.

    Google Scholar 

  • Moore RA, Moore OA, Derry S, Peloso PM, Gammaitoni AR, Wang H. Responder analysis for pain relief and numbers needed to treat in a meta-analysis of Etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice. Ann Rheum Dis. 2010;69(2):374–9.

    Google Scholar 

  • Osani MC, Vaysbrot EE, Zhou M, McAlindon TE, Bannuru RR. Duration of symptom relief and early trajectory of adverse events for oral nonsteroidal antiinflammatory drugs in knee osteoarthritis: A systematic review and Meta-Analysis. Arthritis Care Res (Hoboken). 2020;72(5):641–51.

    Google Scholar 

  • Jones IA, Togashi R, Wilson ML, Heckmann N, Vangsness CT Jr. Intra-articular treatment options for knee osteoarthritis. Nat Rev Rheumatol. 2019;15(2):77–90.

    Google Scholar 

  • Berkovic D, Vallance P, Harris IA, et al. A systematic review and meta-analysis of short-stay programmes for total hip and knee replacement, focusing on safety and optimal patient selection. BMC Med. 2023;21(1):511.

    Google Scholar 

  • Vervullens S, Meert L, Smeets R, et al. Preoperative glycaemic control, number of pain locations, structural knee damage, self-reported central sensitisation, satisfaction and personal control are predictive of 1-year postoperative pain, and change in pain from pre- to 1-year posttotal knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2025;33(1):201–19.

    Google Scholar 

  • Ulivi M, Orlandini L, D’Errico M, et al. Medium-term patient’s satisfaction after primary total knee arthroplasty: enhancing prediction for improved care. Orthop Traumatol Surg Res. 2024;110(2):103734.

    Google Scholar 

  • Viswanathan S, Shi Y, Galipeau J, et al. Mesenchymal stem versus stromal cells: international society for cell & gene therapy (ISCT®) mesenchymal stromal cell committee position statement on nomenclature. Cytotherapy. 2019;21(10):1019–24.

    Google Scholar 

  • Zhou J, Shi Y. Mesenchymal stem/stromal cells (MSCs): origin, immune regulation, and clinical applications. Cell Mol Immunol. 2023;20(6):555–7.

    Google Scholar 

  • Hoang DM, Pham PT, Bach TQ, et al. Stem cell-based therapy for human diseases. Signal Transduct Target Ther. 2022;7(1):272.

    Google Scholar 

  • Meng Z, He D, Wang H, et al. Mapping the knowledge landscape of and emerging future trends in stem cell therapy for osteoarthritis: A bibliometric analysis of the literature from 1998 to 2024. J Multidiscip Healthc. 2025;18:1281–95.

    Google Scholar 

  • Zhou C, Zhang B, Yang Y, et al. Stem cell-derived exosomes: emerging therapeutic opportunities for wound healing. Stem Cell Res Ther. 2023;14(1):107.

    Google Scholar 

  • Théry C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002;2(8):569–79.

    Google Scholar 

  • Jeppesen DK, Fenix AM, Franklin JL, et al. Reassessment Exosome Composition Cell. 2019;177(2):428–e44518.

    Google Scholar 

  • Zou J, Yang W, Cui W, et al. Therapeutic potential and mechanisms of mesenchymal stem cell-derived exosomes as bioactive materials in tendon-bone healing. J Nanobiotechnol. 2023;21(1):14.

    Google Scholar 

  • Yáñez-Mó M, Siljander PR, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4:27066.

    Google Scholar 

  • Zeng Z, Zhou X, Wang Y, et al. Mitophagy-A new target of bone disease. Biomolecules. 2022;12(10):1420.

    Google Scholar 

  • Zeng B, Li Y, Khan N, et al. Yin-Yang: two sides of extracellular vesicles in inflammatory diseases. J Nanobiotechnol. 2024;22(1):514.

    Google Scholar 

  • Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American college of Rheumatology/Arthritis foundation guideline for the management of osteoarthritis of the Hand, Hip, and knee. Arthritis Rheumatol. 2020;72(2):220–33.

    Google Scholar 

  • Sharma L. Osteoarthritis of the knee. N Engl J Med. 2021;384(1):51–9.

    Google Scholar 

  • Hardingham T. Chondroitin sulfate and joint disease. Osteoarthr Cartil. 1998;6(Suppl A):3–5.

  • Tuan RS, Chen AF, Klatt BA. Cartilage regeneration. J Am Acad Orthop Surg. 2013;21(5):303–11.

    Google Scholar 

  • Guilak F, Nims RJ, Dicks A, Wu CL, Meulenbelt I. Osteoarthritis as a disease of the cartilage pericellular matrix. Matrix Biol. 2018;71–72:40–50.

    Google Scholar 

  • Yunus M, Nordin A, Kamal H. Pathophysiological perspective of osteoarthritis. Med (Kaunas). 2020;56(11):614.

    Google Scholar 

  • Peng Z, Sun H, Bunpetch V, et al. The regulation of cartilage extracellular matrix homeostasis in joint cartilage degeneration and regeneration. Biomaterials. 2021;268:120555.

    Google Scholar 

  • Yang CY, Chanalaris A, Troeberg L. ADAMTS and ADAM metalloproteinases in osteoarthritis – looking beyond the ‘usual suspects’. Osteoarthritis Cartilage. 2017;25(7):1000–9.

    Google Scholar 

  • Sang W, Xue S, Jiang Y, et al. METTL3 involves the progression of osteoarthritis probably by affecting ECM degradation and regulating the inflammatory response. Life Sci. 2021;278:119528.

    Google Scholar 

  • Coryell PR, Diekman BO, Loeser RF. Mechanisms and therapeutic implications of cellular senescence in osteoarthritis. Nat Rev Rheumatol. 2021;17(1):47–57.

    Google Scholar 

  • Lieberthal J, Sambamurthy N, Scanzello CR. Inflammation in joint injury and post-traumatic osteoarthritis. Osteoarthritis Cartilage. 2015;23(11):1825–34.

    Google Scholar 

  • Haraden CA, Huebner JL, Hsueh MF, Li YJ, Kraus VB. Synovial fluid biomarkers associated with osteoarthritis severity reflect macrophage and neutrophil related inflammation. Arthritis Res Ther. 2019;21(1):146.

    Google Scholar 

  • Caron MM, Emans PJ, Coolsen MM, et al. Redifferentiation of dedifferentiated human articular chondrocytes: comparison of 2D and 3D cultures. Osteoarthritis Cartilage. 2012;20(10):1170–8.

    Google Scholar 

  • van Gastel N, Stegen S, Eelen G, et al. Lipid availability determines fate of skeletal progenitor cells via SOX9. Nature. 2020;579(7797):111–7.

    Google Scholar 

  • Jouan Y, Bouchemla Z, Bardèche-Trystram B, et al. Lin28a induces SOX9 and chondrocyte reprogramming via HMGA2 and blunts cartilage loss in mice. Sci Adv. 2022;8(34):eabn3106.

    Google Scholar 

  • Liu Y, Xie HQ, Shen B. Type H vessels-a Bridge connecting subchondral bone remodelling and articular cartilage degeneration in osteoarthritis development. Rheumatology (Oxford). 2023;62(4):1436–44.

    Google Scholar 

  • Kahle ER, Patel N, Sreenivasappa HB, Marcolongo MS, Han L. Targeting cell-matrix interface mechanobiology by integrating AFM with fluorescence microscopy. Prog Biophys Mol Biol. 2022;176:67–81.

    Google Scholar 

  • Jia Y, Wang A, Zhao B, et al. An optimized method for obtaining clinical-grade specific cell subpopulations from human umbilical cord-derived mesenchymal stem cells. Cell Prolif. 2022;55(10):e13300.

    Google Scholar 

  • Montemurro T, Lavazza C, Montelatici E, et al. Off-the-Shelf Cord-Blood mesenchymal stromal cells: Production, quality Control, and clinical use. Cells. 2024;13(12):1066.

    Google Scholar 

  • Matas J, García C, Poblete D, et al. A phase I Dose-Escalation clinical trial to assess the safety and efficacy of umbilical Cord-Derived mesenchymal stromal cells in knee osteoarthritis. Stem Cells Transl Med. 2024;13(3):193–203.

    Google Scholar 

  • Chen CF, Hu CC, Wu CT, et al. Treatment of knee osteoarthritis with intra-articular injection of allogeneic adipose-derived stem cells (ADSCs) ELIXCYTE®: a phase I/II, randomized, active-control, single-blind, multiple-center clinical trial. Stem Cell Res Ther. 2021;12(1):562.

    Google Scholar 

  • Lee WS, Kim HJ, Kim KI, Kim GB, Jin W. Intra-Articular injection of autologous adipose Tissue-Derived mesenchymal stem cells for the treatment of knee osteoarthritis: A phase IIb, Randomized, Placebo-Controlled clinical trial. Stem Cells Transl Med. 2019;8(6):504–11.

    Google Scholar 

  • Emadedin M, Labibzadeh N, Liastani MG, et al. Intra-articular implantation of autologous bone marrow-derived mesenchymal stromal cells to treat knee osteoarthritis: a randomized, triple-blind, placebo-controlled phase 1/2 clinical trial. Cytotherapy. 2018;20(10):1238–46.

    Google Scholar 

  • Lee BW, Lee JJ, Jung JY, Ju JH. Intra-Articular injection of human bone Marrow-Derived mesenchymal stem cells in knee osteoarthritis: A Randomized, Double-Blind, controlled trial. Cell Transpl. 2025;34:9636897241303275.

    Google Scholar 

  • Figueroa-Valdés AI, Luz-Crawford P, Herrera-Luna Y, et al. Clinical-grade extracellular vesicles derived from umbilical cord mesenchymal stromal cells: preclinical development and first-in-human intra-articular validation as therapeutics for knee osteoarthritis. J Nanobiotechnol. 2025;23(1):13.

    Google Scholar 

  • Wang Y, Kong Y, Du J, et al. Injection of human umbilical cord mesenchymal stem cells exosomes for the treatment of knee osteoarthritis: from preclinical to clinical research. J Transl Med. 2025;23(1):641.

    Google Scholar 

  • Copp G, Robb KP, Viswanathan S. Culture-expanded mesenchymal stromal cell therapy: does it work in knee osteoarthritis? A pathway to clinical success. Cell Mol Immunol. 2023;20(6):626–50.

    Google Scholar 

  • Wang X, Ouyang L, Chen W, Cao Y, Zhang L. Efficient expansion and delayed senescence of hUC-MSCs by microcarrier-bioreactor system. Stem Cell Res Ther. 2023;14(1):284.

    Google Scholar 

  • Yue S, Zhai G, Zhao S, et al. The biphasic role of the infrapatellar fat pad in osteoarthritis. Biomed Pharmacother. 2024;179:117364.

    Google Scholar 

  • Taheri S, Yoshida T, Böker KO, et al. Investigating the microchannel architectures inside the subchondral bone in relation to estimated hip reaction forces on the human femoral head. Calcif Tissue Int. 2021;109(5):510–24.

    Google Scholar 

  • Warmink K, Rios JL, Varderidou-Minasian S, et al. Mesenchymal stem/stromal cells-derived extracellular vesicles as a potentially more beneficial therapeutic strategy than MSC-based treatment in a mild metabolic osteoarthritis model. Stem Cell Res Ther. 2023;14(1):137.

    Google Scholar 

  • Giorgino R, Albano D, Fusco S, Peretti GM, Mangiavini L, Messina C. Knee osteoarthritis: Epidemiology, Pathogenesis, and mesenchymal stem cells: what else is new? An update. Int J Mol Sci. 2023;24(7):6405.

    Google Scholar 

  • Manferdini C, Maumus M, Gabusi E, et al. Adipose-derived mesenchymal stem cells exert antiinflammatory effects on chondrocytes and synoviocytes from osteoarthritis patients through prostaglandin E2. Arthritis Rheum. 2013;65(5):1271–81.

    Google Scholar 

  • Yang G, Fan X, Liu Y, et al. Immunomodulatory mechanisms and therapeutic potential of mesenchymal stem cells. Stem Cell Rev Rep. 2023;19(5):1214–31.

    Google Scholar 

  • Xu L, Wu Y, Xiong Z, Zhou Y, Ye Z, Tan WS. Mesenchymal stem cells reshape and provoke proliferation of articular chondrocytes by paracrine secretion. Sci Rep. 2016;6:32705.

    Google Scholar 

  • Pers YM, Ruiz M, Noël D, Jorgensen C. Mesenchymal stem cells for the management of inflammation in osteoarthritis: state of the Art and perspectives. Osteoarthritis Cartilage. 2015;23(11):2027–35.

    Google Scholar 

  • Chen X, McClurg A, Zhou GQ, McCaigue M, Armstrong MA, Li G. Chondrogenic differentiation alters the immunosuppressive property of bone marrow-derived mesenchymal stem cells, and the effect is partially due to the upregulated expression of B7 molecules. Stem Cells. 2007;25(2):364–70.

    Google Scholar 

  • Liu H, Kemeny DM, Heng BC, Ouyang HW, Melendez AJ, Cao T. The immunogenicity and Immunomodulatory function of osteogenic cells differentiated from mesenchymal stem cells. J Immunol. 2006;176(5):2864–71.

    Google Scholar 

  • Liu B, Zhang M, Zhao J, Zheng M, Yang H. Imbalance of M1/M2 macrophages is linked to severity level of knee osteoarthritis. Exp Ther Med. 2018;16(6):5009–14.

    Google Scholar 

  • Xie J, Huang Z, Yu X, Zhou L, Pei F. Clinical implications of macrophage dysfunction in the development of osteoarthritis of the knee. Cytokine Growth Factor Rev. 2019;46:36–44.

    Google Scholar 

  • Zhao X, Zhao Y, Sun X, Xing Y, Wang X, Yang Q. Immunomodulation of MSCs and MSC-Derived extracellular vesicles in osteoarthritis. Front Bioeng Biotechnol. 2020;8:575057.

    Google Scholar 

  • Li P, Lv S, Jiang W, et al. Exosomes derived from umbilical cord mesenchymal stem cells protect cartilage and regulate the polarization of macrophages in osteoarthritis. Ann Transl Med. 2022;10(18):976.

    Google Scholar 

  • Li K, Yan G, Huang H, et al. Anti-inflammatory and Immunomodulatory effects of the extracellular vesicles derived from human umbilical cord mesenchymal stem cells on osteoarthritis via M2 macrophages. J Nanobiotechnol. 2022;20(1):38.

    Google Scholar 

  • Zhou H, Shen X, Yan C, et al. Extracellular vesicles derived from human umbilical cord mesenchymal stem cells alleviate osteoarthritis of the knee in mice model by interacting with METTL3 to reduce m6A of NLRP3 in macrophage. Stem Cell Res Ther. 2022;13(1):322.

    Google Scholar 

  • Tian G, Yin H, Zheng J, et al. Promotion of osteochondral repair through immune microenvironment regulation and activation of endogenous chondrogenesis via the release of apoptotic vesicles from donor MSCs. Bioact Mater. 2024;41:455–70.

    Google Scholar 

  • Li Z, Li Q, Tong K, et al. BMSC-derived exosomes promote tendon-bone healing after anterior cruciate ligament reconstruction by regulating M1/M2 macrophage polarization in rats. Stem Cell Res Ther. 2022;13(1):295.

    Google Scholar 

  • Li B, Shen E, Wu Z, et al. BMSC-derived exosomes attenuate rat osteoarthritis by regulating macrophage polarization through PINK1/parkin signaling pathway. Cartilage. 2024:19476035241245805.

  • Sun W, Qu S, Ji M, Sun Y, Hu B. BMP-7 modified exosomes derived from synovial mesenchymal stem cells attenuate osteoarthritis by M2 polarization of macrophages. Heliyon. 2023;9(9):e19934.

    Google Scholar 

  • Zhang S, Chuah SJ, Lai RC, Hui J, Lim SK, Toh WS. MSC exosomes mediate cartilage repair by enhancing proliferation, attenuating apoptosis and modulating immune reactivity. Biomaterials. 2018;156:16–27.

    Google Scholar 

  • Cosenza S, Toupet K, Maumus M, et al. Mesenchymal stem cells-derived exosomes are more immunosuppressive than microparticles in inflammatory arthritis. Theranostics. 2018;8(5):1399–410.

    Google Scholar 

  • Sankaranarayanan J, Lee SC, Kim HK, Kang JY, Kuppa SS, Seon JK. Cinnamaldehyde-Treated bone marrow Mesenchymal-Stem-Cell-Derived exosomes via aqueous Two-Phase system attenuate IL-1β-Induced inflammation and catabolism via modulation of Proinflammatory signaling pathways. Int J Mol Sci. 2024;25(13):7263.

    Google Scholar 

  • Zhou L, Ye H, Liu L, Chen Y. Human bone mesenchymal stem Cell-Derived exosomes inhibit IL-1β-Induced inflammation in osteoarthritis chondrocytes. Cell J. 2021;23(4):485–94.

    Google Scholar 

  • Dong J, Li L, Fang X, Zang M, Exosome-Encapsulated. microRNA-127-3p released from bone Marrow-Derived mesenchymal stem cells alleviates osteoarthritis through regulating CDH11-Mediated Wnt/β-Catenin pathway. J Pain Res. 2021;14:297–310.

    Google Scholar 

  • Haghwerdi F, Khozaei Ravari M, Taghiyar L, et al. Application of bone and cartilage extracellular matrices in articular cartilage regeneration. Biomed Mater. 2021;16(4).

  • Harrell CR, Markovic BS, Fellabaum C, Arsenijevic A, Volarevic V. Mesenchymal stem cell-based therapy of osteoarthritis: current knowledge and future perspectives. Biomed Pharmacother. 2019;109:2318–26.

    Google Scholar 

  • Chen X, Shi Y, Xue P, Ma X, Li J, Zhang J. Mesenchymal stem cell-derived Exosomal microRNA-136-5p inhibits chondrocyte degeneration in traumatic osteoarthritis by targeting ELF3. Arthritis Res Ther. 2020;22(1):256.

    Google Scholar 

  • Tang S, Chen P, Zhang H, et al. Comparison of curative effect of human umbilical Cord-Derived mesenchymal stem cells and their small extracellular vesicles in treating osteoarthritis. Int J Nanomed. 2021;16:8185–202.

    Google Scholar 

  • Liu Y, Zeng Y, Si HB, Tang L, Xie HQ, Shen B. Exosomes derived from human Urine-Derived stem cells overexpressing miR-140-5p alleviate knee osteoarthritis through downregulation of VEGFA in a rat model. Am J Sports Med. 2022;50(4):1088–105.

    Google Scholar 

  • Wang Z, Yan K, Ge G, et al. Exosomes derived from miR-155-5p-overexpressing synovial mesenchymal stem cells prevent osteoarthritis via enhancing proliferation and migration, attenuating apoptosis, and modulating extracellular matrix secretion in chondrocytes. Cell Biol Toxicol. 2021;37(1):85–96.

    Google Scholar 

  • Hunziker EB, Quinn TM, Häuselmann HJ. Quantitative structural organization of normal adult human articular cartilage. Osteoarthritis Cartilage. 2002;10(7):564–72.

    Google Scholar 

  • Zhu Q, Yin F, Qin J, et al. Procr(+) chondroprogenitors sense mechanical stimuli to govern articular cartilage maintenance and regeneration. Cell. 2025;188(19):5194–e21116.

    Google Scholar 

  • Maenohara Y, Chijimatsu R, Tachibana N, et al. Lubricin contributes to homeostasis of articular cartilage by modulating differentiation of superficial zone cells. J Bone Min Res. 2021;36(4):792–802.

    Google Scholar 

  • Zhi Z, Zhang C, Kang J, et al. The therapeutic effect of bone marrow-derived mesenchymal stem cells on osteoarthritis is improved by the activation of the KDM6A/SOX9 signaling pathway caused by exposure to hypoxia. J Cell Physiol. 2020;235(10):7173–82.

    Google Scholar 

  • Li Q, Yu H, Sun M, et al. The tissue origin effect of extracellular vesicles on cartilage and bone regeneration. Acta Biomater. 2021;125:253–66.

    Google Scholar 

  • Chen S, Tang Y, Liu Y, et al. Exosomes derived from miR-375-overexpressing human adipose mesenchymal stem cells promote bone regeneration. Cell Prolif. 2019;52(5):e12669.

    Google Scholar 

  • Zhang S, Jin Z. Bone mesenchymal stem cell-derived extracellular vesicles containing long noncoding RNA NEAT1 relieve osteoarthritis. Oxid Med Cell Longev. 2022;2022:5517648.

  • Ye P, Mi Z, Wei D, Gao P, Ma M, Yang H. miR-3960 from mesenchymal stem cell-derived extracellular vesicles inactivates SDC1/Wnt/β-catenin axis to relieve chondrocyte injury in osteoarthritis by targeting PHLDA2. Stem Cells Int. 2022;2022:9455152.

  • Mao G, Zhang Z, Hu S, et al. Exosomes derived from miR-92a-3p-overexpressing human mesenchymal stem cells enhance chondrogenesis and suppress cartilage degradation via targeting WNT5A. Stem Cell Res Ther. 2018;9(1):247.

    Google Scholar 

  • Zhang B, Tian X, Qu Z, Hao J, Zhang W. Hypoxia-Preconditioned extracellular vesicles from mesenchymal stem cells improve cartilage repair in osteoarthritis. Membr (Basel). 2022;12(2):225.

    Google Scholar 

  • Rong Y, Zhang J, Jiang D, et al. Hypoxic pretreatment of small extracellular vesicles mediates cartilage repair in osteoarthritis by delivering miR-216a-5p. Acta Biomater. 2021;122:325–42.

    Google Scholar 

  • Hu J, Shi ZS, Liu XZ, et al. Exosomes derived from Runx2-overexpressing BMSCs enhance cartilage tissue regeneration and prevent osteoarthritis of the knee in a rabbit model. Stem Cells Int. 2022;2022:6865041.

  • Li F, Xu Z, Xie Z, et al. Adipose mesenchymal stem cells-derived exosomes alleviate osteoarthritis by transporting MicroRNA – 376c-3p and targeting the WNT-beta-catenin signaling axis. Apoptosis. 2023;28(3–4):362–78.

    Google Scholar 

  • Xin Y, Wang YM, Zhang H, et al. Aging adversely impacts biological properties of human bone marrow-derived mesenchymal stem cells: implications for tissue engineering heart valve construction. Artif Organs. 2010;34(3):215–22.

    Google Scholar 

  • Diekman BO, Loeser RF. Aging and the emerging role of cellular senescence in osteoarthritis. Osteoarthritis Cartilage. 2024;32(4):365–71.

    Google Scholar 

  • Xie J, Wang Y, Lu L, et al. Cellular senescence in knee osteoarthritis: molecular mechanisms and therapeutic implications. Ageing Res Rev. 2021;70:101413.

    Google Scholar 

  • Cao H, Chen M, Cui X, et al. Cell-Free osteoarthritis treatment with Sustained-Release of Chondrocyte-Targeting exosomes from umbilical Cord-Derived mesenchymal stem cells to rejuvenate aging chondrocytes. ACS Nano. 2023;17(14):13358–76.

    Google Scholar 

  • Lei Q, Gao F, Liu T, et al. Extracellular vesicles deposit PCNA to rejuvenate aged bone marrow-derived mesenchymal stem cells and slow age-related degeneration. Sci Transl Med. 2021;13(578):eaaz8697. [pii].

    Google Scholar 

  • Gorgun C, Africano C, Ciferri MC, et al. Preconditioned mesenchymal stromal Cell-Derived extracellular vesicles (EVs) counteract inflammaging. Cells. 2022;11(22):3695.

    Google Scholar 

  • Kirkland JL, Tchkonia T. Senolytic drugs: from discovery to translation. J Intern Med. 2020;288(5):518–36.

    Google Scholar 

  • Iqbal Z, Rehman K, Xia J, et al. Biomaterial-assisted targeted and controlled delivery of CRISPR/Cas9 for precise gene editing. Biomater Sci. 2023;11(11):3762–83.

    Google Scholar 

  • Duan L, Xu L, Xu X, et al. Exosome-mediated delivery of gene vectors for gene therapy. Nanoscale. 2021;13(3):1387–97.

    Google Scholar 

  • Feng K, Liu J, Gong L, et al. Engineered MSC-sEVs as a versatile nanoplatform for enhanced osteoarthritis treatment via targeted elimination of senescent chondrocytes and maintenance of cartilage matrix metabolic homeostasis. Adv Sci (Weinh). 2025;12(8):e2413759.

    Google Scholar 

  • Long L, Zou G, Cheng Y, Li F, Wu H, Shen Y. MATN3 delivered by exosome from synovial mesenchymal stem cells relieves knee osteoarthritis: evidence from in vitro and in vivo studies. J Orthop Translat. 2023;41:20–32.

    Google Scholar 

  • Tao SC, Yuan T, Zhang YL, Yin WJ, Guo SC, Zhang CQ. Exosomes derived from miR-140-5p-overexpressing human synovial mesenchymal stem cells enhance cartilage tissue regeneration and prevent osteoarthritis of the knee in a rat model. Theranostics. 2017;7(1):180–95.

    Google Scholar 

  • Liu X, Rong N, Tian Z, et al. Acoustothermal transfection for cell therapy. Sci Adv. 2024;10(16):eadk1855.

    Google Scholar 

  • Zhu S, Xuan J, Shentu Y, et al. Effect of chitin-architected Spatiotemporal three-dimensional culture microenvironments on human umbilical cord-derived mesenchymal stem cells. Bioact Mater. 2024;35:291–305.

    Google Scholar 

  • Chen JG, Zhang EC, Wan YY, Huang TY, Wang YC, Jiang HY. Engineered hsa-miR-455-3p-Abundant extracellular vesicles derived from 3D-Cultured adipose mesenchymal stem cells for Tissue-Engineering hyaline cartilage regeneration. Adv Healthc Mater. 2024;13(18):e2304194.

    Google Scholar 

  • Yan L, Li D, Li S, et al. Exosomes derived from 3D-cultured MSCs alleviate knee osteoarthritis by promoting M2 macrophage polarization through miR-365a-5p and inhibiting TLR2/Myd88/NF-κB pathway. Chem Eng J. 2024;497:154432.

    Google Scholar 

  • Liu W, Li L, Rong Y, et al. Hypoxic mesenchymal stem cell-derived exosomes promote bone fracture healing by the transfer of miR-126. Acta Biomater. 2020;103:196–212.

    Google Scholar 

  • Zhen G, Wen C, Jia X, et al. Inhibition of TGF-β signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nat Med. 2013;19(6):704–12.

    Google Scholar 

  • Pang L, Jin H, Lu Z, et al. Treatment with mesenchymal stem Cell-Derived Nanovesicle-Containing gelatin methacryloyl hydrogels alleviates osteoarthritis by modulating chondrogenesis and macrophage polarization. Adv Healthc Mater. 2023;12(17):e2300315.

    Google Scholar 

  • Guo S, Debbi L, Zohar B, et al. Stimulating extracellular vesicles production from engineered tissues by mechanical forces. Nano Lett. 2021;21(6):2497–504.

    Google Scholar 

  • Wang P, Zhao H, Chen W, et al. Cell-free osteoarthritis treatment with dual-engineered chondrocyte-targeted extracellular vesicles derived from mechanical loading primed mesenchymal stem cells. J Tissue Eng. 2025;16:20417314241312563.

    Google Scholar 

  • Lu M, Lou A, Gao J, et al. Quercetin-primed MSC exosomes synergistically attenuate osteoarthritis progression. J Orthop Surg Res. 2025;20(1):373.

    Google Scholar 

  • Kao TW, Liu YS, Yang CY, Lee OK. Mechanotransduction of mesenchymal stem cells and hemodynamic implications. Chin J Physiol. 2023;66(2):55–64.

    Google Scholar 

  • Skibber MA, Olson SD, Prabhakara KS, Gill BS, Cox CS Jr. Enhancing mesenchymal stromal cell potency: inflammatory licensing via mechanotransduction. Front Immunol. 2022;13:874698.

    Google Scholar 

  • Colombini A, Ragni E, Mortati L, et al. Adipose-Derived mesenchymal stromal cells treated with Interleukin 1 beta produced Chondro-Protective vesicles able to fast penetrate in cartilage. Cells. 2021;10(5):1180.

    Google Scholar 

  • Kim M, Shin DI, Choi BH, Min BH. Exosomes from IL-1β-Primed mesenchymal stem cells inhibited IL-1β- and TNF-α-Mediated inflammatory responses in Osteoarthritic SW982 cells. Tissue Eng Regen Med. 2021;18(4):525–36.

    Google Scholar 

  • Chen M, Liu Y, Cao Y, et al. Remodeling the Proinflammatory microenvironment in osteoarthritis through Interleukin-1 beta tailored exosome cargo for inflammatory regulation and cartilage regeneration. ACS Nano. 2025;19(4):4924–41.

    Google Scholar 

  • Duan A, Shen K, Li B, et al. Extracellular vesicles derived from LPS-preconditioned human synovial mesenchymal stem cells inhibit extracellular matrix degradation and prevent osteoarthritis of the knee in a mouse model. Stem Cell Res Ther. 2021;12(1):427.

    Google Scholar 

  • Molnar V, Matišić V, Kodvanj I, et al. Cytokines and chemokines involved in osteoarthritis pathogenesis. Int J Mol Sci. 2021;22(17):9208.

    Google Scholar 

  • Wu J, Wu J, Xiang W, et al. Engineering exosomes derived from TNF-α preconditioned IPFP-MSCs enhance both yield and therapeutic efficacy for osteoarthritis. J Nanobiotechnol. 2024;22(1):555.

    Google Scholar 

  • Yamamoto K, Troeberg L, Scilabra SD, et al. LRP-1-mediated endocytosis regulates extracellular activity of ADAMTS-5 in articular cartilage. FASEB J. 2013;27(2):511–21.

    Google Scholar 

  • Wang R, Xu B. TGF-β1-modified MSC-derived Exosomal miR-135b attenuates cartilage injury via promoting M2 synovial macrophage polarization by targeting MAPK6. Cell Tissue Res. 2021;384(1):113–27.

    Google Scholar 

  • Zhao T, Mu Y, Deng H, et al. Research hotspots and trends of mesenchymal stem cell-derived extracellular vesicles for drug delivery: a bibliometric and visualization analysis from 2013 to 2023. Front Cell Dev Biol. 2024;12:1412363.

    Google Scholar 

  • Hao D, Lopez JM, Chen J, et al. Engineering extracellular microenvironment for tissue regeneration. Bioeng (Basel). 2022;9(5):202.

    Google Scholar 

  • Weng Z, Zhang B, Wu C, et al. Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer. J Hematol Oncol. 2021;14(1):136.

    Google Scholar 

  • Liang Y, Xu X, Li X, et al. Chondrocyte-Targeted MicroRNA delivery by engineered exosomes toward a Cell-Free osteoarthritis therapy. ACS Appl Mater Interfaces. 2020;12(33):36938–47.

    Google Scholar 

  • Xu X, Liang Y, Li X, et al. Exosome-mediated delivery of Kartogenin for chondrogenesis of synovial fluid-derived mesenchymal stem cells and cartilage regeneration. Biomaterials. 2021;269:120539.

    Google Scholar 

  • Liang Y, Xu X, Xu L, et al. Chondrocyte-specific genomic editing enabled by hybrid exosomes for osteoarthritis treatment. Theranostics. 2022;12(11):4866–78.

    Google Scholar 

  • Zhang H, Yan W, Wang J, et al. Surface functionalization of exosomes for chondrocyte-targeted SiRNA delivery and cartilage regeneration. J Control Release. 2024;369:493–505.

    Google Scholar 

  • Midekessa G, Godakumara K, Ord J, et al. Zeta potential of extracellular vesicles: toward Understanding the attributes that determine colloidal stability. ACS Omega. 2020;5(27):16701–10.

    Google Scholar 

  • Shamji MH, Boyle RJ. Adverse effects of Dupilumab, effects of peanut OIT on the gut Microbiome and allergy training in the united Kingdom. Clin Exp Allergy. 2025;55(5):364–6.

    Google Scholar 

  • Desai N, Rana D, Patel M, et al. Nanoparticle therapeutics in clinical perspective: Classification, marketed Products, and regulatory landscape. Small. 2025;21(29):e2502315.

    Google Scholar 

  • Zhang C, Pathrikar TV, Baby HM, et al. Charge-Reversed exosomes for targeted gene delivery to cartilage for osteoarthritis treatment. Small Methods. 2024;8(9):e2301443.

    Google Scholar 

  • Feng K, Xie X, Yuan J, et al. Reversing the surface charge of MSC-derived small extracellular vesicles by εPL-PEG-DSPE for enhanced osteoarthritis treatment. J Extracell Vesicles. 2021;10(13):e12160.

    Google Scholar 

  • Qiu B, Xu X, Yi P, Hao Y. Curcumin reinforces MSC-derived exosomes in attenuating osteoarthritis via modulating the miR-124/NF-kB and miR-143/ROCK1/TLR9 signalling pathways. J Cell Mol Med. 2020;24(18):10855–65.

    Google Scholar 

  • Zhang Y, Liu K, Ma X, et al. Therapeutic effects of puerarin loaded bone marrow mesenchymal stem Cell-Derived exosomes in a rat model of osteoarthritis. Chem Biodivers. 2025;22(3):e202402095.

    Google Scholar 

  • Tao Y, Zhou J, Wang Z, et al. Human bone mesenchymal stem cells-derived Exosomal miRNA-361-5p alleviates osteoarthritis by downregulating DDX20 and inactivating the NF-κB signaling pathway. Bioorg Chem. 2021;113:104978.

    Google Scholar 

  • Khan NA, Asim M, Biswas KH, et al. Exosome nanovesicles as potential biomarkers and immune checkpoint signaling modulators in lung cancer microenvironment: recent advances and emerging concepts. J Exp Clin Cancer Res. 2023;42(1):221.

    Google Scholar 

  • Xu X, Xu L, Wen C, Xia J, Zhang Y, Liang Y. Programming assembly of biomimetic exosomes: an emerging theranostic nanomedicine platform. Mater Today Bio. 2023;22:100760.

    Google Scholar 

  • Gulen MF, Samson N, Keller A, et al. cGAS-STING drives ageing-related inflammation and neurodegeneration. Nature. 2023;620(7973):374–80.

    Google Scholar 

  • Feng G, Wu Y, He X, et al. Lubricated hydrogel with STING-inhibiting exos protect the osteoarthritis by suppressing the senescent microenvironment. Nano Today. 2025;62:102688.

    Google Scholar 

  • Lagneau N, Tournier P, Nativel F, et al. Harnessing cell-material interactions to control stem cell secretion for osteoarthritis treatment. Biomaterials. 2023;296:122091.

    Google Scholar 

  • Cheng J, Sun Y, Ma Y, Ao Y, Hu X, Meng Q. Engineering of MSC-Derived exosomes: A promising Cell-Free therapy for osteoarthritis. Membr (Basel). 2022;12(8):739.

    Google Scholar 

  • Lu H, Zhang Y, Xiong S, et al. Modulatory role of silver nanoparticles and mesenchymal stem Cell-Derived Exosome-Modified barrier membrane on macrophages and osteogenesis. Front Chem. 2021;9:699802.

    Google Scholar 

  • Lei H, Cao H, Chen X, et al. A functionalized 3D-Printed Ti-6Al‐4V cell climbing frame inspired by marine sponges to recruit and rejuvenate autologous BMSCs in osteoporotic bone repair. Adv Mater. 2025;37(11):e2413238.

    Google Scholar 

  • Luo L, Zheng W, Li J, et al. 3D-Printed titanium trabecular scaffolds with sustained release of Hypoxia-Induced exosomes for Dual-Mimetic bone regeneration. Adv Sci (Weinh). 2025;12(23):e2500599.

    Google Scholar 

  • Fernandes JS, Gentile P, Pires RA, Reis RL, Hatton PV. Multifunctional bioactive glass and glass-ceramic biomaterials with antibacterial properties for repair and regeneration of bone tissue. Acta Biomater. 2017;59:2–11.

    Google Scholar 

  • Liu A, Lin D, Zhao H, et al. Optimized BMSC-derived osteoinductive exosomes immobilized in hierarchical scaffold via lyophilization for bone repair through Bmpr2/Acvr2b competitive receptor-activated Smad pathway. Biomaterials. 2021;272:120718.

    Google Scholar 

  • Bohner M, Santoni B, Döbelin N. β-tricalcium phosphate for bone substitution: synthesis and properties. Acta Biomater. 2020;113:23–41.

    Google Scholar 

  • Zhang J, Liu X, Li H, et al. Exosomes/tricalcium phosphate combination scaffolds can enhance bone regeneration by activating the PI3K/Akt signaling pathway. Stem Cell Res Ther. 2016;7(1):136.

    Google Scholar 

  • Zhang B, Huang J, Liu J, Lin F, Ding Z, Xu J. Injectable composite hydrogel promotes osteogenesis and angiogenesis in spinal fusion by optimizing the bone marrow mesenchymal stem cell microenvironment and exosomes secretion. Mater Sci Eng C Mater Biol Appl. 2021;123:111782.

    Google Scholar 

  • Garcia-Aponte OF, Kahlenberg S, Kouroupis D, Egger D, Kasper C. Effects of hydrogels on mesenchymal Stem/Stromal cells paracrine activity and extracellular vesicles production. J Extracell Vesicles. 2025;14(3):e70057.

    Google Scholar 

  • Cao H, Duan L, Zhang Y, Cao J, Zhang K. Current hydrogel advances in physicochemical and biological response-driven biomedical application diversity. Signal Transduct Target Ther. 2021;6(1):426.

    Google Scholar 

  • Guan P, Liu C, Xie D, et al. Exosome-loaded extracellular matrix-mimic hydrogel with anti-inflammatory property Facilitates/promotes growth plate injury repair. Bioact Mater. 2022;10:145–58.

    Google Scholar 

  • Li Q, Xu S, Feng Q, et al. 3D printed silk-gelatin hydrogel scaffold with different porous structure and cell seeding strategy for cartilage regeneration. Bioact Mater. 2021;6(10):3396–410.

    Google Scholar 

  • Lenzini S, Bargi R, Chung G, Shin JW. Matrix mechanics and water permeation regulate extracellular vesicle transport. Nat Nanotechnol. 2020;15(3):217–23.

    Google Scholar 

  • Zeng J, Sun P, Zhao Y, Fang X, Wu Z, Qi X. Bone mesenchymal stem cell-derived exosomes involved co-delivery and synergism effect with Icariin via mussel-inspired multifunctional hydrogel for cartilage protection. Asian J Pharm Sci. 2023;18(3):100799.

    Google Scholar 

  • Zheng Y, Fu L, Zhang Z, et al. Three-Dimensional Bioprinting of growth differentiation factor 5-Preconditioned mesenchymal stem Cell-Derived exosomes facilitates articular cartilage endogenous regeneration. ACS Nano. 2025;19(16):15281–301.

    Google Scholar 

  • Chen P, Zheng L, Wang Y, et al. Desktop-stereolithography 3D printing of a radially oriented extracellular matrix/mesenchymal stem cell exosome Bioink for osteochondral defect regeneration. Theranostics. 2019;9(9):2439–59.

    Google Scholar 

  • Li Q, Yu H, Zhao F, et al. 3D printing of Microenvironment-Specific bioinspired and Exosome-Reinforced hydrogel scaffolds for efficient cartilage and subchondral bone regeneration. Adv Sci (Weinh). 2023;10(26):e2303650.

    Google Scholar 

  • Tu C, Gao X, Zheng H, et al. Innovative injectable, self-healing, exosome cross-linked biomimetic hydrogel for cartilage regeneration. J Control Release. 2025;381:113608.

    Google Scholar 

  • Gao J, Xia Z, Mary HB, Joseph J, Luo JN, Joshi N. Overcoming barriers for intra-articular delivery of disease-modifying osteoarthritis drugs. Trends Pharmacol Sci. 2022;43(3):171–87.

    Google Scholar 

  • D’Souza N, Charlton J, Grayson J, et al. Are biomechanics during gait associated with the structural disease onset and progression of lower limb osteoarthritis? A systematic review and meta-analysis. Osteoarthritis Cartilage. 2022;30(3):381–94.

    Google Scholar 

  • Zhang X, Ma S, Naz SI, et al. Comprehensive characterization of pathogenic synovial fluid extracellular vesicles from knee osteoarthritis. Clin Immunol. 2023;257:109812.

    Google Scholar 

  • Chen P, Tang S, Gao H, et al. Wharton’s jelly mesenchymal stem cell-derived small extracellular vesicles as natural nanoparticles to attenuate cartilage injury via MicroRNA regulation. Int J Pharm. 2022;623:121952.

    Google Scholar 

  • Li L, Wang F, Zhu D, Hu S, Cheng K, Li Z. Engineering exosomes and exosome-like nanovesicles for improving tissue targeting and retention. Fundam Res. 2025;5(2):851–67.

    Google Scholar 

  • Li Y, Wang Y, Zhao H, Pan Q, Chen G. Engineering strategies of Plant-Derived Exosome-Like nanovesicles: current knowledge and future perspectives. Int J Nanomed. 2024;19:12793–815.

    Google Scholar 

  • Zhao B, Wei J, Jiang Z, et al. Mesenchymal stem cell-derived exosomes: an emerging therapeutic strategy for hepatic ischemia-reperfusion injury. Stem Cell Res Ther. 2025;16(1):178.

    Google Scholar 

  • Soland MA, Bego M, Colletti E, et al. Mesenchymal stem cells engineered to inhibit complement-mediated damage. PLoS ONE. 2013;8(3):e60461.

    Google Scholar 

  • Li Y, Chen F, Zhao W, et al. Harnessing extracellular vesicles from adipose-derived stem cells for the treatment of 4-vinylcyclohexene diepoxide-induced premature ovarian insufficiency. Stem Cell Res Ther. 2025;16(1):425.

    Google Scholar 

  • Continue Reading